MIR6511A3

Across TCGA pan-cancer cohorts, MIR6511A3 Mutation is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR6511A3 data layer compared with 1 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR6511A3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6511A3 expression acts as an unfavorable survival marker.

COAD and BLCA are the cancer types where MIR6511A3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.315	0.805	<.001	25	view →
BLCA	DFS	Median	III,IV	0.090	0.572	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6511A3–COAD (OS)

Open the COAD breakdown →